- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Aarti Drugs Limited has submitted a certificate for the quarter ended December 31, 2024, confirming compliance with SEBI regulations regarding the dematerialisation of securities. The company’s registrar, MUFG Intime India Pvt. Ltd., verified that all securities received for dematerialisation were accepted and properly listed on the relevant stock exchanges.
This update reinforces the company's commitment to operational transparency and compliance, enhancing investor confidence in its governance practices. Investors may view this as a positive reflection of the company's operational integrity, potentially fostering a more favorable market sentiment towards its shares.